Amprion lands funding to expand brain disease testing

As investment fuels brain diagnostics, Amprion’s expansion highlights growing belief that better tests are just as important as better drugs. The race against neurodegenerative disease has largely focused on finding the next breakthrough drug. However, a growing number of researchers are beginning to ask a different question: what if one of the biggest bottlenecks isn’t […] The post Amprion lands funding to expand brain disease testing appeared first on Longevity.Technology .

This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.